+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hormones Market Research Report by Type, by Route of administration, by End-User, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5519530
  • Report
  • January 2022
  • Region: Global
  • 182 Pages
  • 360iResearch™
UP TO OFF
until Dec 31st 2022

FEATURED COMPANIES

  • Allergan Inc.
  • BIOSTATION
  • Endo Pharmaceuticals Inc.
  • InMode Ltd.
  • Noven Therapeutics, LLC.
  • Opt Health
The Global Hormones Market size was estimated at USD 3,802.98 million in 2020, is expected to reach USD 4,519.08 million in 2021, and is projected to grow at a CAGR of 19.19% to reach USD 13,000.34 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Hormones to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Amino Acid Derivatives, Peptide Hormones, and Steroid Hormones.
  • Based on Route of administration, the market was studied across Intravenous, Nasal, Oral, Suppository, and Topical.
  • Based on End-User, the market was studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, the market was studied across the Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Ongoing research by the publisher amplifies their research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Hormones Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Hormones Market, including Acerus Pharmaceuticals Corporation, Allergan Inc., American Regent, Inc., Bayers AG, BIOSTATION, BioTE Medical, Defy Medical LLC, Endo Pharmaceuticals Inc., Ferring B.V., Full Life Wellness Center, GeneScience Pharmaceuticals Co. LTD, InMode Ltd., McGuff Pharmaceuticals, Inc., MERCK KGAA, NextGenRx Compounding Pharmacy, Novartis AG, Noven Therapeutics, LLC., Novo Nordisk A/S, Nueva Aesthetics, Opt Health, Orion Pharma AB, Pfizer Inc., and Slayback Pharma LLC.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Hormones Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Hormones Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Hormones Market?
4. What is the competitive strategic window for opportunities in the Global Hormones Market?
5. What are the technology trends and regulatory frameworks in the Global Hormones Market?
6. What is the market share of the leading vendors in the Global Hormones Market?
7. What modes and strategic moves are considered suitable for entering the Global Hormones Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Allergan Inc.
  • BIOSTATION
  • Endo Pharmaceuticals Inc.
  • InMode Ltd.
  • Noven Therapeutics, LLC.
  • Opt Health
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing awareness about menopausal signs and related treatment
5.1.1.2. Rising geriatric population and hormonal imbalance disorders
5.1.1.3. Growing number of product launches of growth hormone
5.1.2. Restraints
5.1.2.1. High cost of hormone treatment
5.1.3. Opportunities
5.1.3.1. Advancements in hormone replacements
5.1.3.2. Increasing investments and collaborations in hormone replacement therapies
5.1.4. Challenges
5.1.4.1. Adverse health effects of hormone treatment
5.2. Cumulative Impact of COVID-19

6. Hormones Market, by Type
6.1. Introduction
6.2. Amino Acid Derivatives
6.3. Peptide Hormones
6.4. Steroid Hormones

7. Hormones Market, by Route of administration
7.1. Introduction
7.2. Intravenous
7.3. Nasal
7.4. Oral
7.5. Suppository
7.6. Topical

8. Hormones Market, by End-User
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Retail Pharmacies

9. Americas Hormones Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Hormones Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand

11. Europe, Middle East & Africa Hormones Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Acerus Pharmaceuticals Corporation
13.2. Allergan Inc.
13.3. American Regent, Inc.
13.4. Bayers AG
13.5. BIOSTATION
13.6. BioTE Medical
13.7. Defy Medical LLC
13.8. Endo Pharmaceuticals Inc.
13.9. Ferring B.V.
13.10. Full Life Wellness Center
13.11. GeneScience Pharmaceuticals Co. LTD
13.12. InMode Ltd.
13.13. McGuff Pharmaceuticals, Inc.
13.14. MERCK KGAA
13.15. NextGenRx Compounding Pharmacy
13.16. Novartis AG
13.17. Noven Therapeutics, LLC.
13.18. Novo Nordisk A/S
13.19. Nueva Aesthetics
13.20. Opt Health
13.21. Orion Pharma AB
13.22. Pfizer Inc.
13.23. Slayback Pharma LLC

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing


List of Figures
Figure 1. Global Hormones Market: Research Process
Figure 2. Global Hormones Market: Market Dynamics
Figure 3. Global Hormones Market Size, by Type, 2020 Vs 2027 (%)
Figure 4. Global Hormones Market Size, by Type, 2020 Vs 2027 (USD Million)
Figure 5. Competitive Strategic Window For Global Hormones Market Size, by Type, 2027
Figure 6. Global Hormones Market Size, by Amino Acid Derivatives, 2018-2027 (USD Million)
Figure 7. Global Hormones Market Size, by Amino Acid Derivatives, by Region, 2020 Vs 2027 (USD Million)
Figure 8. Global Hormones Market Size, by Peptide Hormones, 2018-2027 (USD Million)
Figure 9. Global Hormones Market Size, by Peptide Hormones, by Region, 2020 Vs 2027 (USD Million)
Figure 10. Global Hormones Market Size, by Steroid Hormones, 2018-2027 (USD Million)
Figure 11. Global Hormones Market Size, by Steroid Hormones, by Region, 2020 Vs 2027 (USD Million)
Figure 12. Global Hormones Market Size, by Route Of Administration, 2020 Vs 2027 (%)
Figure 13. Global Hormones Market Size, by Route Of Administration, 2020 Vs 2027 (USD Million)
Figure 14. Competitive Strategic Window For Global Hormones Market Size, by Route Of Administration, 2027
Figure 15. Global Hormones Market Size, by Intravenous, 2018-2027 (USD Million)
Figure 16. Global Hormones Market Size, by Intravenous, by Region, 2020 Vs 2027 (USD Million)
Figure 17. Global Hormones Market Size, by Nasal, 2018-2027 (USD Million)
Figure 18. Global Hormones Market Size, by Nasal, by Region, 2020 Vs 2027 (USD Million)
Figure 19. Global Hormones Market Size, by Oral, 2018-2027 (USD Million)
Figure 20. Global Hormones Market Size, by Oral, by Region, 2020 Vs 2027 (USD Million)
Figure 21. Global Hormones Market Size, by Suppository, 2018-2027 (USD Million)
Figure 22. Global Hormones Market Size, by Suppository, by Region, 2020 Vs 2027 (USD Million)
Figure 23. Global Hormones Market Size, by Topical, 2018-2027 (USD Million)
Figure 24. Global Hormones Market Size, by Topical, by Region, 2020 Vs 2027 (USD Million)
Figure 25. Global Hormones Market Size, by End-User, 2020 Vs 2027 (%)
Figure 26. Global Hormones Market Size, by End-User, 2020 Vs 2027 (USD Million)
Figure 27. Competitive Strategic Window For Global Hormones Market Size, by End-User, 2027
Figure 28. Global Hormones Market Size, by Hospital Pharmacies, 2018-2027 (USD Million)
Figure 29. Global Hormones Market Size, by Hospital Pharmacies, by Region, 2020 Vs 2027 (USD Million)
Figure 30. Global Hormones Market Size, by Online Pharmacies, 2018-2027 (USD Million)
Figure 31. Global Hormones Market Size, by Online Pharmacies, by Region, 2020 Vs 2027 (USD Million)
Figure 32. Global Hormones Market Size, by Retail Pharmacies, 2018-2027 (USD Million)
Figure 33. Global Hormones Market Size, by Retail Pharmacies, by Region, 2020 Vs 2027 (USD Million)
Figure 34. Americas Hormones Market Size, 2018-2027 (USD Million)
Figure 35. Argentina Hormones Market Size, 2018-2027 (USD Million)
Figure 36. Brazil Hormones Market Size, 2018-2027 (USD Million)
Figure 37. Canada Hormones Market Size, 2018-2027 (USD Million)
Figure 38. Mexico Hormones Market Size, 2018-2027 (USD Million)
Figure 39. United States Hormones Market Size, 2018-2027 (USD Million)
Figure 40. Asia-Pacific Hormones Market Size, 2018-2027 (USD Million)
Figure 41. Australia Hormones Market Size, 2018-2027 (USD Million)
Figure 42. China Hormones Market Size, 2018-2027 (USD Million)
Figure 43. India Hormones Market Size, 2018-2027 (USD Million)
Figure 44. Indonesia Hormones Market Size, 2018-2027 (USD Million)
Figure 45. Japan Hormones Market Size, 2018-2027 (USD Million)
Figure 46. Malaysia Hormones Market Size, 2018-2027 (USD Million)
Figure 47. Philippines Hormones Market Size, 2018-2027 (USD Million)
Figure 48. Singapore Hormones Market Size, 2018-2027 (USD Million)
Figure 49. South Korea Hormones Market Size, 2018-2027 (USD Million)
Figure 50. Taiwan Hormones Market Size, 2018-2027 (USD Million)
Figure 51. Thailand Hormones Market Size, 2018-2027 (USD Million)
Figure 52. Europe, Middle East & Africa Hormones Market Size, 2018-2027 (USD Million)
Figure 53. France Hormones Market Size, 2018-2027 (USD Million)
Figure 54. Germany Hormones Market Size, 2018-2027 (USD Million)
Figure 55. Italy Hormones Market Size, 2018-2027 (USD Million)
Figure 56. Netherlands Hormones Market Size, 2018-2027 (USD Million)
Figure 57. Qatar Hormones Market Size, 2018-2027 (USD Million)
Figure 58. Russia Hormones Market Size, 2018-2027 (USD Million)
Figure 59. Saudi Arabia Hormones Market Size, 2018-2027 (USD Million)
Figure 60. South Africa Hormones Market Size, 2018-2027 (USD Million)
Figure 61. Spain Hormones Market Size, 2018-2027 (USD Million)
Figure 62. United Arab Emirates Hormones Market Size, 2018-2027 (USD Million)
Figure 63. United Kingdom Hormones Market Size, 2018-2027 (USD Million)
Figure 64. Global Hormones Market: Fpnv Positioning Matrix
Figure 65. Global Hormones Market: Share, by Key Player, 2020
Figure 66. Competitive Scenario Analysis In Global Hormones Market, by Type


List of Tables
Table 1. Global Hormones Market: Market Segmentation & Coverage
Table 2. United States Dollar Exchange Rate, 2016-2020
Table 3. Global Hormones Market Size, by Type, 2018-2027 (USD Million)
Table 4. Global Hormones Market Size, by Amino Acid Derivatives, by Region, 2018-2027 (USD Million)
Table 5. Global Hormones Market Size, by Peptide Hormones, by Region, 2018-2027 (USD Million)
Table 6. Global Hormones Market Size, by Steroid Hormones, by Region, 2018-2027 (USD Million)
Table 7. Global Hormones Market Size, by Route Of Administration, 2018-2027 (USD Million)
Table 8. Global Hormones Market Size, by Intravenous, by Region, 2018-2027 (USD Million)
Table 9. Global Hormones Market Size, by Nasal, by Region, 2018-2027 (USD Million)
Table 10. Global Hormones Market Size, by Oral, by Region, 2018-2027 (USD Million)
Table 11. Global Hormones Market Size, by Suppository, by Region, 2018-2027 (USD Million)
Table 12. Global Hormones Market Size, by Topical, by Region, 2018-2027 (USD Million)
Table 13. Global Hormones Market Size, by End-User, 2018-2027 (USD Million)
Table 14. Global Hormones Market Size, by Hospital Pharmacies, by Region, 2018-2027 (USD Million)
Table 15. Global Hormones Market Size, by Online Pharmacies, by Region, 2018-2027 (USD Million)
Table 16. Global Hormones Market Size, by Retail Pharmacies, by Region, 2018-2027 (USD Million)
Table 17. Americas Hormones Market Size, 2018-2027 (USD Million)
Table 18. Argentina Hormones Market Size, 2018-2027 (USD Million)
Table 19. Brazil Hormones Market Size, 2018-2027 (USD Million)
Table 20. Canada Hormones Market Size, 2018-2027 (USD Million)
Table 21. Mexico Hormones Market Size, 2018-2027 (USD Million)
Table 22. United States Hormones Market Size, 2018-2027 (USD Million)
Table 23. Asia-Pacific Hormones Market Size, 2018-2027 (USD Million)
Table 24. Australia Hormones Market Size, 2018-2027 (USD Million)
Table 25. China Hormones Market Size, 2018-2027 (USD Million)
Table 26. India Hormones Market Size, 2018-2027 (USD Million)
Table 27. Indonesia Hormones Market Size, 2018-2027 (USD Million)
Table 28. Japan Hormones Market Size, 2018-2027 (USD Million)
Table 29. Malaysia Hormones Market Size, 2018-2027 (USD Million)
Table 30. Philippines Hormones Market Size, 2018-2027 (USD Million)
Table 31. Singapore Hormones Market Size, 2018-2027 (USD Million)
Table 32. South Korea Hormones Market Size, 2018-2027 (USD Million)
Table 33. Taiwan Hormones Market Size, 2018-2027 (USD Million)
Table 34. Thailand Hormones Market Size, 2018-2027 (USD Million)
Table 35. Europe, Middle East & Africa Hormones Market Size, 2018-2027 (USD Million)
Table 36. France Hormones Market Size, 2018-2027 (USD Million)
Table 37. Germany Hormones Market Size, 2018-2027 (USD Million)
Table 38. Italy Hormones Market Size, 2018-2027 (USD Million)
Table 39. Netherlands Hormones Market Size, 2018-2027 (USD Million)
Table 40. Qatar Hormones Market Size, 2018-2027 (USD Million)
Table 41. Russia Hormones Market Size, 2018-2027 (USD Million)
Table 42. Saudi Arabia Hormones Market Size, 2018-2027 (USD Million)
Table 43. South Africa Hormones Market Size, 2018-2027 (USD Million)
Table 44. Spain Hormones Market Size, 2018-2027 (USD Million)
Table 45. United Arab Emirates Hormones Market Size, 2018-2027 (USD Million)
Table 46. United Kingdom Hormones Market Size, 2018-2027 (USD Million)
Table 47. Global Hormones Market: Scores
Table 48. Global Hormones Market: Business Strategy
Table 49. Global Hormones Market: Product Satisfaction
Table 50. Global Hormones Market: Ranking
Table 51. Global Hormones Market: Share, by Key Player, 2020
Table 52. Global Hormones Market: Merger & Acquisition
Table 53. Global Hormones Market: Agreement, Collaboration, & Partnership
Table 54. Global Hormones Market: New Product Launch & Enhancement
Table 55. Global Hormones Market: Investment & Funding
Table 56. Global Hormones Market: Award, Recognition, & Expansion
Table 57. Global Hormones Market: License & Pricing
Note: Product cover images may vary from those shown
  • Acerus Pharmaceuticals Corporation
  • Allergan Inc.
  • American Regent, Inc.
  • Bayers AG
  • BIOSTATION
  • BioTE Medical
  • Defy Medical LLC
  • Endo Pharmaceuticals Inc.
  • Ferring B.V.
  • Full Life Wellness Center
  • GeneScience Pharmaceuticals Co. LTD
  • InMode Ltd.
  • McGuff Pharmaceuticals, Inc.
  • MERCK KGAA
  • NextGenRx Compounding Pharmacy
  • Novartis AG
  • Noven Therapeutics, LLC.
  • Novo Nordisk A/S
  • Nueva Aesthetics
  • Opt Health
  • Orion Pharma AB
  • Pfizer Inc.
  • Slayback Pharma LLC
Note: Product cover images may vary from those shown

Loading
LOADING...